Natco Pharma Ltd News

Natco Pharma gains nearly 3% on ₹2,500 crore South Africa investment plan

Natco Pharma has announced investments of nearly ₹2,500 crore in South Africa, including infusing ₹1,400 crore in its arm in the country with an aim to enter new geographies.

Stocks to Watch today: TCS, Tata Steel, GMR Airports, M&M, SBI, HFCL & more

Stocks to watch today: TCS, SBI, Tata Steel, GMR Airports, M&M, HFCL, RIL, Fortis Healthcare, JSW Infra, Swiggy, Pidilite, Shree Cement, among others, will be in focus today

Patent expiry: A $5 bn opportunity for Indian pharma majors, says report

Lupin, Intas Pharmaceuticals, Sun Pharma, MSN Laboratories, Natco Pharma, Zydus Life Sciences and Dr Reddy's Laboratories are some of the companies, the note said, that could potentially benefit.

Natco Pharma stock price slips 20% in 2 days; should you buy, sell or hold?

Natco Pharma's management expects better FY28 with traction coming from Canada, Brazil and India besides some niche launches in the US which can translate into 15- 25 per cent PAT growth.

10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt

Companies including Dr. Reddy's Laboratories, Sun Pharma, Zydus Lifesciences, Natco Pharma, Alkem Laboratories, and Torrent Pharmaceuticals have developed their own formulations

Demerger buzz, semaglutide injection plans sees Natco Pharma shares jump 4%

Demerger: Natco Pharma shares gained nearly 4 per cent in trade on Friday ahead of next week's board meeting to consider a demerger proposal

Natco rallies 5%, nears 52-week high; what's driving pharma stock?

In the past four trading days, the stock price of Natco Pharma has surged 10 per cent after the company announced the launch of Pomalidomide Capsules (generic of Pomalyst) in the US market.

Natco Pharma shares rise 3% in weak mkt on launching generic Pomalyst in US

The buying on the counter came after Natco Pharma, along with Breckenridge Pharmaceutical, launched Pomalidomide Capsules, a generic version of Pomalyst by Celgene, in the US market.

Pharma stocks in demand; Torrent hits new high; Natco up 6% on huge volumes

At 01:13 PM on Tuesday; Nifty Pharma index, the top gainer among sectoral indices, was up 0.2 per cent, as compared to 1.1 per cent decline in the Nifty 50.

Natco Pharma zooms 11% on getting CDSCO approval for Semaglutide injections

The buying on the counter came after Natco Pharma received approval from the Central Drugs Standard Control Organisation (CDSCO) for Semaglutide in India

Stocks to Watch today: Coal India, SpiceJet, HUL, Biocon, Infosys, IRCTC

Stocks to watch today, Friday, February 13, 2026: Market participants will keep an eye on SpiceJet, Coal India, Biocon, Infosys, Mishra Dhatu Nigam, Indraprastha Gas share prices today